Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-04-12This Trial is an Open Label, Parallel Cohort, Phase II Study Evaluating the Efficacy of the Heat Shock Protein 90 (Hsp90) Inhibitor STA-9090 in Patients With Unresectable Stage III or Stage IV Melanoma Who Were Intolerant of, or Progressed on, Prior Tyrosine Kinase Inhibitor Treatment. Two Cohorts Will Enroll Concurrently. One Cohort Will be Composed of Patients With Melanoma Expressing a Mutation in the Protein BRAF and the Other Cohort Will be Composed of Patients With Melanoma Expressing Wild-type BRAF.
-
CLINICAL_TRIALS study record update · 2017-04-11A Phase II Study of Pegylated Interferon Alfa-2b in AJCC Stage III (TxN1-2M0) Melanoma Subjects After Regional Lymph Node Dissection in Russia
-
CLINICAL_TRIALS study record update · 2017-04-06Leflunomide in Combination With Vemurafenib in Patients With V600 Mutant Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-04-05Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes
-
CLINICAL_TRIALS study record update · 2017-03-31Comparing Wound Eversion and Clinical Outcomes in Surgical Wound Repair With Subcuticular Set-back Versus Traditional Vertical Mattress Suturing Techniques
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-03-30Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Association With Chemotherapy in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-29a Phase II Trial With Continuous Intravenous Infusion of Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-28A Pilot/Phase I Study of Panobinostat (LBH589) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-24A Randomized Double-Blind Phase III Study of Ipilimumab Administered at 3 mg/kg Versus at 10 mg /kg in Subjects With Previously Treated or Untreated Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-10A Pilot Study of Ipilimumab in Subjects With Stage IV Melanoma Receiving Palliative Radiation Therapy
-
CLINICAL_TRIALS study record update · 2017-03-09COMBAT 1: A Phase II Trial of Combined BRAF-Targeted Therapy and Immunotherapy for Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-07An Open-Label, Phase Ib Dose Escalation Trial of Oral Combination Therapy With MSC1936369B and SAR245409 in Subjects With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-03-03An Exploratory Study of Adjuvant Therapy of Pegylated Interferon-Alfa 2b Plus Melanoma Peptide Vaccine in Patients With Resected Stage II and III (N1a, N2a) Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-03A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Evaluating the Efficacy of ABT-888 in Combination With Temozolomide Versus Temozolomide Alone in Subjects With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-02-20A Phase I Study of Bolus High Dose Interleukin-2 With Sorafenib (BAY 43-9006) in Patients With Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-02-14A Phase 2, Multicenter, Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec in Subjects With Unresected, Stage IIIB to IVM1c Melanoma
-
CLINICAL_TRIALS study record update · 2017-02-03Real-Time NIR-Guided Sentinel Lymph Node Mapping in Melanoma
-
CLINICAL_TRIALS study record update · 2017-02-02Infrared Fluorescence Guided Surgery for Sentinel Node Identification in Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2017-02-01A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2017-01-2618F-Labeled Picolinamide PET-CT in the Management of Patients With Melanoma: The Radiation Dosimetry and Diagnostic Applications in Melanoma Patients
-
CLINICAL_TRIALS study record update · 2017-01-10Phase I Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Immune Checkpoint Inhibitors in Metastatic Melanoma: Dose Limiting Toxicity and Abscopal Effect
-
CLINICAL_TRIALS study record update · 2017-01-09Phase II, Multi-center, Open-label Study of Single-agent LGX818 Followed by a Rational Combination With Agents After Progression on LGX818, in Adult Patients With Locally Advanced or Metastatic BRAF V600 Melanoma
-
CLINICAL_TRIALS study record update · 2017-01-09A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen.
-
CLINICAL_TRIALS study record update · 2016-12-29A Two-Arm, Single Center Pase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients
-
CLINICAL_TRIALS study record update · 2016-12-16Evaluation of the Safety and Immunogenicity of Intratumoral Injection of Interferon Gamma During Vaccination in Patients With Subcutaneous or Cutaneous Metastases of Melanoma